FDA approves Aduhelm (aducanumab) using the accelerated approval pathway used for drugs treating serious or life-threatening illness that provide a meaningful therapeutic advantage over existing treatments. The drug is shown […]
Author Archive for: firstname.lastname@example.org
About Susan Fox-Rosellini
This author has not written his bio yet.
But we are proud to say that Susan Fox-Rosellini contributed 1 entries already.